Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Outcome Of Board Meeting Held On Friday, 28.05.2021

The Board of Directors in its Meeting held on Friday, 28th May, 2021 at 04:00 p.m. at the Corporate Office of the Company at 3rd Floor, Empire House, 214, Dr. D. N. Road, Fort, Mumbai - 400 001, inter-alia took the following decisions: 1.Considered and approved Standalone Audited Financial Results for the quarter and year ended 31st March, 2021 duly reviewed by the Audit Committee. 2.Considered and approved Statutory Auditor's Report and Standalone Audited Financial Statements for the year ended 31st March, 2021 duly reviewed by the Audit Committee. 3.Considered appointment of M/s. Sarda Soni Associates as Internal Auditor for the Financial Year 2021-2022. 4.Considered and took on record Secretarial Audit Report issued from HS Associates, Practising Company Secretary. 5.Considered and approved draft Report of Board of Directors, Management Discussion & Analysis Report along with other supporting documents forming of Annual Report for the Financial Year 2020-2021
28-05-2021
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday, 28.05.2021 For Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.2021

CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2021 ,inter alia, to consider and approve This is to inform that meeting of the Board of Directors of the Company is scheduled on Friday, 28.05.2021, inter alia, to consider and approve the Standalone Audited Financial Results of the Company for the quarter and year ended March 31, 2021
18-05-2021
Bigul

Chemo Pharma Laboratories Ltd - 506365 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Submission of Certificate of Non- Applicability of Regulation 24A of SEBI (Listing Obligations and Disclosure Requirement) (Amendment) Regulations, 2018
23-04-2021
Bigul

Chemo Pharma Laboratories Ltd - 506365 - Submission Of Certificate Pursuant To Regulation 40(9&10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Issued By Practising Company Secretary For The Period From October 1, 2020 To March 31, 2021 In Respect Of Transfer/ Transmission Of Securities Etc. Of The Company

Submission of Certificate Pursuant to Regulation 40(9&10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 issued by Practising Company Secretary for the period from October 1, 2020 to March 31, 2021 in respect of transfer/ transmission of securities etc. of the Company
12-04-2021
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholding for the Period Ended March 31, 2021

Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
10-04-2021
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
05-04-2021
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Compliance Certificate For The Half-Year Ended March 31, 2021 Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

Submission of Compliance Certificate for the half-year ended March 31, 2021 pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015
05-04-2021
Bigul

CHEMO PHARMA LABORATORIES LTD. - 506365 - Statement Of Investor Complaints For The Quarter Ended March 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashok SomaniDesignation :- Managing Director / Whole Time Director
05-04-2021
Bigul

Chemo Pharma Laboratories Ltd - 506365 - Closure of Trading Window

Intimation of Closure of Trading Window for the quarter ended 31.03.2021
30-03-2021
Next Page
Close

Let's Open Free Demat Account